UPS paid $5.4 billion in dividends in 2025, surpassing its free cash flow of $4.8 billion, signaling potential payout risks. Similar concerns apply to Pfizer, AGNC Investment, and Kraft Heinz, where dividends outpace earnings or cash flow, threatening future cuts. Investors should watch upcoming cash flow reports and company actions closely, as these dividends may not be sustainable without borrowing or asset sales. The article highlights the importance of verifying cash flow coverage before relying on high dividend yields.
Pfizer shares trade at USD 30.44 on Pluang as of Nov 04, 2026, with a dividend yield of 5.61%. AGNC Investment's stock price is USD 8.56, offering a high dividend yield of 16.57%. These figures highlight the ongoing investor interest in dividend-paying stocks despite concerns over payout sustainability.
Pfizer reported third-quarter earnings that exceeded analyst expectations, with adjusted earnings per share of 87 cents versus the expected 73 cents, and revenue of $16.58 billion beating the $15.87 billion forecast. The company raised its full-year ...
Regeneron Pharmaceuticals' stock surged 12% after reporting a 36% revenue increase to $5.1 billion in Q3 2026, beating analyst expectations. The boost was largely due to its partnership with Sanofi, with Dupixent sales rising 35%, and record sales of...
Pfizer's stock rating was lowered from Buy to Hold due to increasing analyst skepticism about its growth prospects and declining revenue and earnings expected through 2029. Despite management's optimistic projections and new pipeline drugs, including...
